Position in JNJ
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$6,575,791
+$416,637 QoQ
Shares Held
25,892
+2.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#1,402
of 4,664 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Journey Advisory Group, LLC holds $51,629,041 across 8 Drug Manufacturers - General names. JNJ ranks #3 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,437 | $25,712,183 | |
| 2 | ABBV |
AbbVie Inc.
|
47,472 | $11,945,854 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
25,892 | $6,575,791 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,149 | $2,974,646 | |
| 5 | AMGN |
Amgen Inc
|
6,427 | $2,327,345 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
17,141 | $987,664 | |
| 7 | PFE |
Pfizer Inc
|
34,607 | $833,336 | |
| 8 | NVS |
Novartis AG
|
1,737 | $272,222 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,575,791 | 25,892 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $6,159,154 | 25,197 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $5,793,772 | 27,996 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $4,612,137 | 24,874 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,007,701 | 26,237 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $4,394,594 | 26,499 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,368,391 | 30,206 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $4,895,184 | 30,206 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,421,340 | 30,250 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $4,986,306 | 31,521 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $5,250,006 | 33,495 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,992,707 | 44,897 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $10,108,471 | 61,071 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $9,293,645 | 59,959 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $10,240,223 | 57,969 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $8,390,332 | 51,361 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $8,616,690 | 48,542 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $6,725,878 | 37,950 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,273,650 | 36,673 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,550,593 | 34,369 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,841,515 | 35,459 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,585,927 | 33,988 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $5,289,541 | 33,610 | Shares | Sole | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||